LatGYNious pelvic mesh for treating pelvic organ prolapse
Official title: Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Lateral Suspension (LatGYNious)
Run by A.M.I. Agency for Medical Innovations GmbH · NCT07066761 · Data updated 2026-11-12
This study will try the LatGYNious preformed mesh during laparoscopic lateral suspension surgery to see if it improves prolapse symptoms in women who need surgical repair.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 85 (estimated) |
| Sponsor | A.M.I. Agency for Medical Innovations GmbH Industry-sponsored |
| Drugs / interventions | immunotherapy |
| Locations | 5 sites (Sankt Johann in Tirol, Tyrol and 4 other locations) |
| Status | Recruiting |
| Started | November 1, 2025 |
| Main results expected | December 2027 |
| Study ends | April 2028 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07066761 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women with symptomatic pelvic organ prolapse (grade 2 or higher) who are eligible for laparoscopic surgical repair and can attend follow-up visits.
✕Probably not a fit
Patients who previously had a mesh implant for prolapse, have known polypropylene allergy, active relevant cancer, pregnancy, or contraindications to the device are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The device is a preformed pelvic mesh that combines an ultra-light, elastic polypropylene body with reinforced mesh arms designed for strong lateral fixation. Patients with symptomatic pelvic organ prolapse grade 2 or higher who are candidates for surgical repair will receive laparoscopic lateral suspension using the LatGYNious implant, with the mesh posterior portion removed if uterus preservation is planned. The study will collect clinical data on safety outcomes and anatomical and functional performance over scheduled follow-up visits. The goal is to characterize complication rates, fixation strength, and prolapse recurrence after implantation.
Why it matters
Potential benefit: If successful, the LatGYNious mesh could provide firmer, longer-lasting support and lower recurrence of prolapse after surgery.
How similar studies have gone: Similar mesh-based repairs and laparoscopic lateral suspension procedures have shown improved anatomical outcomes in some series, but results are mixed because mesh-related complications have also been reported.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Symptomatic prolapse in one of the 3 compartments from grade 2 with or without uterus * Subject is candidate for a surgical treatment of pelvic organ prolapse * Subject is willing and able to cooperate with follow-up examinations * Subject has been informed of the study procedures and the treatment and has signed an informed consent form and provided authorization to use and disclose information for research purposes. Exclusion Criteria: * Previous surgical treatment with a mesh implant for pelvic organ prolapse (mesh implant in anterior or posterior compartment) * Active immunotherapy which may negatively affect the treatment with a surgical mesh * Active cancer of the vagina / cervix / rectum * . known or suspected hypersensitivity to Polypropylene * Pregnancy * participation in another study at the same time * Unable to understand study requirements or is unable to comply with follow-up schedule * Contraindicated according to the instruction for use of the device
Where it's running
-
BZK St. Johann in Tirol
Sankt Johann in Tirol, Tyrol, Austria Recruiting -
Universitätsklinikum Wiener Neustadt, Klinische Abteilung für Gynäkologie und Geburtshilfe
Wiener Neustadt, Austria Recruiting -
Universitätsklinik Brandenburg a.d. Havel, Klinik für Frauenheilkunde und Geburtshilfe
Brandenburg, Germany Not yet recruiting -
Krankenhaus St. Joseph-Stift Bremen
Bremen, Germany Not yet recruiting -
Medizincampus Bodensee - Klinik Tettnang
Tettnang, Germany Not yet recruiting
Study contacts
- Principal investigator: Tina Cadenbach-Blome, Dr. med. — Medizincampus Bodensee - Klinik Tettnang
- Study coordinator: Florian Blab
- Email: florian.blab@ami.at
- Phone: +43 5522 90505 4062
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pelvic floor mesh used in laparoscopic sacrocolpopexy to repair pelvic organ prolapse
This study tests the ProGYNious mesh to see if it safely and effectively repairs pelvic organ prolapse in adults undergoing laparoscopic surgery.
-
Pre-incisional ropivacaine plus Diprospan for pain after laparoscopic surgery
This study tests whether injecting ropivacaine with Diprospan before surgery reduces pain after laparoscopic gallbladder, appendix, or hernia operations compared with ropivacaine alone.
-
Remimazolam and Sevoflurane: How they work together during anesthesia
This study tests how remimazolam and sevoflurane interact during general anesthesia in adults undergoing laparoscopic surgery to see if their combined effect is stronger, the same, or weaker than expected.
-
Risk predictor for new urinary incontinence after prolapse surgery
This study tests a model to predict which women might develop new stress urinary incontinence after pelvic organ prolapse repair.
-
Pre-incisional ropivacaine plus triamcinolone for pain after laparoscopic surgery
This trial tests whether injecting ropivacaine with or without triamcinolone before incision can reduce postoperative pain in adults undergoing common laparoscopic procedures like gallbladder removal, appendix removal, or hernia repair.
-
Superior hypogastric plexus block to improve recovery after laparoscopic colorectal cancer surgery
This will test whether adding a superior hypogastric plexus block helps adults having laparoscopic colorectal cancer surgery recover faster and have less pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.